# Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

> **NCT02060786** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 90 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** generic clopidogrel (Plavitor® )
- **DRUG:** original clopidogrel (Plavix® )

## Key facts

- **NCT ID:** NCT02060786
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2014-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02060786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02060786, "Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02060786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*